Fullife Healthcare Raises ₹300 Cr for Global Wellness Expansion

Fullife Healthcare, the parent company behind popular direct-to-consumer health brands Fast&Up and Chicnutrix, has successfully closed a ₹300 crore (approximately $32 million) Series D funding round. The investment was spearheaded by Elev8 Venture Partners, signaling strong confidence in the company's expansion trajectory within the rapidly growing nutraceuticals market.

This latest capital infusion is earmarked for significant global expansion, building on Fullife Healthcare's existing presence in over 40 countries, with key markets including the United States, Europe, and the Gulf region. The funds will also be strategically deployed to enhance manufacturing capabilities, broaden distribution networks, strengthen retail partnerships, and amplify digital marketing efforts. Furthermore, the company plans to introduce innovative new product delivery formats and venture into adjacent wellness categories such as digestive health, sleep support, and advanced protein nutrition.

Founded in 2011, Fullife Healthcare has established a robust portfolio of over 100 Stock Keeping Units (SKUs) catering to hydration, metabolic health, sports nutrition, and beauty wellness. Its flagship brand, Fast&Up, is renowned for its effervescent tablets addressing diverse needs from daily nutrition and energy to weight management and athletic performance. Complementing this is Chicnutrix, a beauty-focused brand offering advanced formulations for skin health, alongside specialized products like the hangover relief line, NightOut.

The company's growth story is further underscored by its cumulative funding, now exceeding $60 million. Prior to this Series D, Fullife Healthcare garnered support from notable investors including Six Sense Ventures and Kotak Securities. A significant $22 million Series C round in 2021 was led by Morgan Stanley Private Equity Asia. The company also boasts a roster of high-profile celebrity backers, including Bollywood actors Shilpa Shetty and Varun Dhawan.

Fullife Healthcare operates in a dynamic and increasingly competitive segment of the health and wellness industry. The global dietary supplements market is projected to reach substantial figures in the coming years, driven by heightened consumer awareness of preventative health and personalized nutrition. Within India, the direct-to-consumer nutraceuticals space is experiencing accelerated growth, attracting both established conglomerates and agile startups.

The effervescent supplement niche, where Fast&Up holds a strong position, is particularly active, with rivals such as Plix, Wellbeing Nutrition, and Oziva also vying for market share. The competitive intensity is further amplified by the strategic entry of legacy pharmaceutical and consumer goods giants like Dabur, Marico, and USV Pharma into the D2C nutraceuticals arena, signaling a maturing market and a drive towards broader consumer engagement.